Effects of carnosine supplementation on glucose metabolism: Pilot clinical trial

Obesity

Volumn 24, Issue 5, 2016, Pages 1027-1034

  De Courten, Barbora ^a,b   Jakubova, Michaela ^c,d   De Courten, Maximilian P J ^e   Kukurova, Ivica Just ^f,g   Vallova, Silvia ^c,d   Krumpolec, Patrik ^c   Valkovic, Ladislav ^f,g   Kurdiova, Timea ^c   Garzon, Davide ^h   Barbaresi, Silvia ⁱ   Teede, Helena J ^a,b   Derave, Wim ⁱ   Krssak, Martin ^f,g   Aldini, Giancarlo ^h   Ukropec, Jozef ^c   Ukropcova, Barbara ^c,d  

^a Alfred Centre   (Australia)

^b SOUTHERN HEALTH   (Australia)

^c INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^d Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^e VICTORIA UNIVERSITY   (Australia)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g INSTITUTE FOR MICROELECTRONICS   (Austria)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CARNOSINE; GLUCOSE; PLACEBO; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE; TREATMENT DURATION; URINE LEVEL; ANALYSIS; BLOOD; BODY WEIGHT; DIET RESTRICTION; DIETARY SUPPLEMENT; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

ADULT; BLOOD GLUCOSE; BODY WEIGHT; CARNOSINE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FASTING; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PILOT PROJECTS; PLACEBOS; RISK FACTORS;

EID: 84963611518     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21434     Document Type: Article

References (40)

1. Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF., Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care 2007; 30: 1562-1566.
2. Fox CS, Pencina MJ, Wilson PW, Paynter NP, Vasan RS, D'Agostino RB, Sr., Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study. Diabetes Care 2008; 31: 1582-1584.
3. Chez MG, Buchanan CP, Aimonovitch MC, et al., Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders. J Child Neurol 2002; 17: 833-837.
4. Boldyrev A, Fedorova T, Stepanova M, et al., Carnosine [corrected] increases efficiency of DOPA therapy of Parkinson's disease: a pilot study. Rejuvenation Res 2008; 11: 821-827.
5. Chengappa KN, Turkin SR, DeSanti S, et al., A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improve cognition in schizophrenia. Schizophr Res 2012; 142: 145-152.
6. Aldini G, Facino RM, Beretta G, Carini M., Carnosine and related dipeptides as quenchers of reactive carbonyl species: from structural studies to therapeutic perspectives. BioFactors 2005; 24: 77-87.
7. Slowinska-Lisowska M, Zembron-Lacny A, Rynkiewicz M, Rynkiewicz T, Kopec W., Influence of l-carnosine on pro-antioxidant status in elite kayakers and canoeists. Acta Physiol Hung 2014; 101: 461-470.
8. Lombardi C, Carubelli V, Lazzarini V, et al., Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. Nutrition 2015; 31: 72-78.
9. Yapislar H, Taskin E., Lcarnosine alters some hemorheologic and lipid peroxidation parameters in nephrectomized rats. Med Sci Monit 2014; 20: 399-405.
10. Niijima A, Okui T, Matsumura Y, et al., Effects of L-carnosine on renal sympathetic nerve activity and DOCA-salt hypertension in rats. Auton Neurosci 2002; 97: 99-102.
11. Sauerhofer S, Yuan G, Braun GS, et al., L-carnosine, a substrate of carnosinase-1, influences glucose metabolism. Diabetes 2007; 56: 2425-2432.
12. Lee YT, Hsu CC, Lin MH, Liu KS, Yin MC., Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. Eur J Pharmacol 2005; 513: 145-150.
13. Nagai K, Tanida M, Niijima A, et al., Role of L-carnosine in the control of blood glucose, blood pressure, thermogenesis, and lipolysis by autonomic nerves in rats: involvement of the circadian clock and histamine. Amino Acids 2012; 43: 97-109.
14. Aldini G, Orioli M, Rossoni G, et al., The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats. J Cellul Mol Med 2011; 15: 1339-1354.
15. Pfister F, Riedl E, Wang Q, et al., Oral carnosine supplementation prevents vascular damage in experimental diabetic retinopathy. Cell Physiol Biochem 2011; 28: 125-136.
16. Koppel H, Riedl E, Braunagel M, et al., L-carnosine inhibits high-glucose-mediated matrix accumulation in human mesangial cells by interfering with TGF-beta production and signalling. Nephrol Dial Transplant 2011; 26: 3852-3858.
17. Gualano B, Everaert I, Stegen S, et al., Reduced muscle carnosine content in type 2, but not in type 1 diabetic patients. Amino Acids 2012; 43: 21-24.
18. Stegen S, Everaert I, Deldicque L, et al., Muscle histidine-containing dipeptides are elevated by glucose intolerance in both rodents and men. PloS One 2015; 10: e0121062
19. Hipkiss AR, Michaelis J, Syrris P., Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent. FEBS Lett 1995; 371: 81-85.
20. Aldini G, Granata P, Carini M., Detoxification of cytotoxic alpha,beta-unsaturated aldehydes by carnosine: characterization of conjugated adducts by electrospray ionization tandem mass spectrometry and detection by liquid chromatography/mass spectrometry in rat skeletal muscle. J Mass Spectrom 2002; 37: 1219-1228.
21. Pavlov AR, Revina AA, Dupin AM, Boldyrev AA, Yaropolov AI., The mechanism of interaction of carnosine with superoxide radicals in water solutions. Biochim Biophys Acta 1993; 1157: 304-312.
22. Boldyrev AA, Aldini G, Derave W., Physiology and pathophysiology of carnosine. Physiol Rev 2013; 93: 1803-1845.
23. Orioli M, Aldini G, Benfatto MC, Facino RM, Carini M., HNE Michael adducts to histidine and histidine-containing peptides as biomarkers of lipid-derived carbonyl stress in urines: LC-MS/MS profiling in Zucker obese rats. Anal Chem 2007; 79: 9174-9184.
24. Baba SP, Hoetker JD, Merchant M, et al., Role of aldose reductase in the metabolism and detoxification of carnosine-acrolein conjugates. J Biol Chem 2013; 288: 28163-28179.
25. Szwergold BS., Carnosine and anserine act as effective transglycating agents in decomposition of aldose-derived Schiff bases. Biochem Biophys Res Commun 2005; 336: 36-41.
26. Despres JP, Lemieux I, Dagenais GR, Cantin B, Lamarche B., HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study. Atherosclerosis 2000; 153: 263-272.
27. Adelmann K, Frey D, Riedl E, et al., Different conformational forms of serum carnosinase detected by a newly developed sandwich ELISA for the measurements of carnosinase concentrations. Amino Acids 2012; 43: 143-151.
28. Stegen S, Everaert I, Deldicque L, et al., Muscle histidine-containing dipeptides in relation to glucose intolerance. PloS One 2015 Mar 24; 10 (3): e0121062. doi: 10.1371/journal.pone.0121062
29. Just KI, Valkovič L, Ukropec J, et al., Improved spectral resolution and high reliability of in vivo 1H MRS at 7T allows characterization of effect of acute exercise on carnosine in skeletal muscle. NMR Biomed, 2016; 29: 24-32.
30. de Courten B, Kurdiova T, de Courten MPJ, et al., Muscle carnosine is associated with cardiometabolic risk factors in humans. PloS One 2015 Oct 6; 10 (10): e0138707 doi: 10.1371/journal.pone.0138707.
31. Aldini G, Carini M, Yeum KJ, Vistoli G., Novel molecular approaches for improving enzymatic and nonenzymatic detoxification of 4-hydroxynonenal: toward the discovery of a novel class of bioactive compounds. Free Radic Biol Med 2014; 69: 145-156.
32. Sourris KC, Lyons JG, de Courten MP, et al., c-Jun NH2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-kappaB activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individuals. Diabetes 2009; 58: 1259-1265.
33. Uribarri J, Cai W, Ramdas M, et al., Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care 2011; 34: 1610-1616.
34. Kong X, Ma MZ, Huang K, et al., Increased plasma levels of the methylglyoxal in patients with newly diagnosed type 2 diabetes 2. J Diabetes 2014; 6: 535-540.
35. Kulebyakin K, Karpova L, Lakonsteva E, Krasavin M, Boldyrev A., Carnosine protects neurons against oxidative stress and modulates the time profile of MAPK cascade signaling. Amino Acids 2012; 43: 91-96.
36. Brown BE, Kim CH, Torpy FR, et al., Supplementation with carnosine decreases plasma triglycerides and modulates atherosclerotic plaque composition in diabetic apo E(-/-) mice. Atherosclerosis 2014; 232: 403-409.
37. Kawaguchi K, Matsumoto T, Kumazawa Y., Effects of antioxidant polyphenols on TNF-alpha-related diseases. Curr Top Med Chem 2011; 11: 1767-1779.
38. Ririe DG, Roberts PR, Shouse MN, Zaloga GP., Vasodilatory actions of the dietary peptide carnosine. Nutrition 2000; 16: 168-172.
39. Aydin AF, Kusku-Kiraz Z, Dogru-Abbasoglu S, Uysal M., Effect of carnosine treatment on oxidative stress in serum, apoB-containing lipoproteins fraction and erythrocytes of aged rats. Pharmacol Rep 2010; 62: 733-739.
40. Greene SM, Margolis FL, Grillo M, Fisher H., Enhanced carnosine (beta-alanyl-L-histidine) breakdown and histamine metabolism following treatment with compound 48/80. Eur J Pharmacol 1984; 99: 79-84.